Repligen appoints Olivier Loeillot as President and CCO; Hunt remains CEO

REPLIGEN CORP

Loeillot appointed President and Chief Commercial Officer effective Oct 2, 2023; reports to CEO Tony Hunt.
Base salary $600k, target bonus 75% of base, signing bonus $1.35M, equity $4M vesting over 5 years.
Hunt relinquishes President role effective Oct 2 but remains CEO; Loeillot has 20+ yr bioprocess experience from Cytiva/GE and Lonza.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Tony Hunt

President

RGEN · REPLIGEN CORP

Effective: 2023-10-02
Successor: Olivier Loeillot
Filed: October 2, 2023, 7:59 PM ET

In connection with Mr. Hunt’s and the rest of the Board’s appointment of Mr. Loeillot’s as President and Chief Commercial Officer, Mr. Hunt will relinquish his role of President, effective October 2, 2023.

Appointed

Olivier Loeillot

President and Chief Commercial Officer

RGEN · REPLIGEN CORP

Effective: 2023-10-02
Filed: October 2, 2023, 7:59 PM ET

On October 2, 2023, Repligen Corporation (the “Company”) announced that Olivier Loeillot would be joining the Company as its President and Chief Commercial Officer, effective October 2, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tony Hunt changed role as President at REPLIGEN CORP.

Action: relinquish
Role: President

Exact text from the filing

In connection with Mr. Hunt’s and the rest of the Board’s appointment of Mr. Loeillot’s as President and Chief Commercial Officer, Mr. Hunt will relinquish his role of President, effective October 2, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Olivier Loeillot was appointed as President and Chief Commercial Officer at REPLIGEN CORP.

Action: appointed
Role: President and Chief Commercial Officer

Exact text from the filing

On October 2, 2023, Repligen Corporation (the “Company”) announced that Olivier Loeillot would be joining the Company as its President and Chief Commercial Officer, effective October 2, 2023 (the “Effective Date”).

View on SEC.gov

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-23-248189

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.